American Society of Hematology

Fig. 1.

Fig. 1. CR duration (- - -) and survival ( — — ) for all patients with AML with t(8; 21).

CR duration (- - -) and survival ( — — ) for all patients with AML with t(8; 21).

This Feature Is Available To Subscribers Only

Sign In or Create an Account